中國置業投資(00736.HK)延期提交內部監控顧問書面報吿
格隆匯3月3日丨中國置業投資(00736.HK)公吿,自2022年1月21日委任內部監控顧問後,內部監控顧問立即開始與公司共同工作,對公司的內部監控進行全面檢討。但由於(其中包括)內部監控顧問及公司就檢討的工作安排因惡化的新型冠狀病毒疫情受到不利影響,故檢討的進度嚴重受到影響,而內部監控顧問及公司需要更多時間以完成書面報吿。因此,公司已申請,而上市科亦已同意,將公司遞交內部監控顧問書面報吿的最後期限由2022年3月3日延長至2022年3月31日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.